Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
FEMASYS INC | Chief Reg & Clinical Officer | Stock Option (Right to Buy) | 23.6K | Jan 28, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FEMY | FEMASYS INC | Jan 28, 2025 | 3 | $0 | 4 | Jan 30, 2025 | Chief Reg & Clinical Officer |
FEMY | FEMASYS INC | Feb 1, 2024 | 1 | $0 | 4 | Feb 2, 2024 | SVP, Regulatory & Clinical |
FEMY | FEMASYS INC | Oct 10, 2023 | 1 | $0 | 4 | Nov 1, 2023 | SVP, Regulatory & Clinical |
FEMY | FEMASYS INC | Oct 10, 2022 | 1 | $0 | 4 | Oct 17, 2022 | SVP, Regulatory & Clinical |
FEMY | FEMASYS INC | Oct 10, 2022 | 0 | $0 | 3 | Oct 17, 2022 | SVP, Regulatory & Clinical |